From Central Office
Vox Sanguinis highlights
Fresh from the press
Avril Swarts, Karin van den Berg, Marion Vermeulen, Ute Jentsch, Darryl Creel, Ronel Swanevelder, Jennifer J. Hemingway-Foday, Edward L. Murphy, Brian Custer
Article Highlights:
- The study confirmed known sexual risks as primary risk factors for incident infections in South African blood donors.
- Risk factors were different for men and women, and included some unexpected risk behaviours.
- The challenges involved in obtaining donor disclosure during selection and the importance of donor education are evident.
First published: 14 July 2025
Ananda J. Thomas, Janet Adegboye, Emmarie Myers, Anjana Sekaran, Una E. Choi, Jana Christian, Elizabeth A. Hendricks, Mellany Stanislaus, Jamie D. Murphy, Ahizechukwu Eke, Arthur J. Vaught, Linda M. S. Resar, Steven M. Frank
Article Highlights:
- In this study, we describe methods of specialized care designed for patients who decline transfusion for religious or personal reasons.
- With coordinated bloodless care delivered by a multidisciplinary care team, there were no deaths in the bloodless or the standard care cohorts.
- Morbid event rates were low in the bloodless (1.5%) and standard care (0.8%) cohorts.
First published: 10 June 2025
Frederik Banch Clausen, Åsa Hellberg, Cécile Toly-Ndour, Emilie Thorup Nielsen, Masja de Haas, The Noninvasive Fetal Antigen Genotyping Survey Group
Article Highlights:
- Noninvasive fetal antigen genotyping is used for predicting fetal blood groups during pregnancy.
- Fetal RHD screening can be used to guide targeted use of Rh prophylaxis.
- Noninvasive fetal antigen genotyping and fetal RHD screening are well integrated into clinical routine in many countries.
First published: 9 June 2025
Michel-Andrés García-Otálora, Carl McDonald, Jennifer Bearne, Bethany Brown, Anthea Cheng, Catherine Humbrecht, Pierre Tiberghien, Sandra Ramirez-Arcos, for the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria
Article Highlights:
- Platelet component (PC) screening with automated microbial culture methods has significantly enhanced product safety.
- Treatment of PC with pathogen reduction technologies has also significantly enhanced product safety.
- A residual safety risk posed by challenging bacteria isolated from breakthrough post-PC screening or pathogen reduction treatment highlights the importance of continuous vigilance to improve current practices.
First published: 9 June 2025